Treatment with metformin and pioglitazone, may be associated with lower rates of new AF.5,118 Recent studies investigating SGLT2 inhibitors show a lower risk of incident AF and AF-related complications compared with untreated populations, although these studies were not specifically designed to detect AF119,120. This evidence concerns the gene SLC5A2 and atrial fibrillation.